This two volume publication about current innovations in primary open angle glaucoma has persevered to come out with a comprehensive review of the latest publications in the world of glaucoma. The list of contributors includes clinicians from the field of...
A new report highlights how 76% of UK hospitals now offer patients the opportunity to take part in studies of eye disease to improve research and innovation. ‘Ophthalmology research in the UK’s National Health Service: the structure and performance of...
Know’st thou the land where lemon-trees do bloom,And oranges like gold in leafy gloom; A gentle wind from deep blue heaven blows, The myrtle thick, and high the laurel grows? ‘Tis there! ‘tis there, O my beloved one, I with...
iPhone slowdown In early 2018 users discovered that Apple was slowing down older iPhones intentionally. The reported reason was to prolong the usable battery life. These changes were made without the knowledge or consent of owners. Unsurprisingly, a community backlash...
Frenchman Louis Braille was in his teens in the mid-1820s when he began developing the six-dot tactile code that enables millions of blind and partially sighted people around the world to access the power of literacy. Two centuries on from...
As indicated in an earlier article in Eye News [1] Dr Cullen was invited in 2000 to the Singapore National Eye Centre (SNEC) as visiting Professor with a specific remit to set up a specialist neuro-ophthalmology service, which was the...
Robotic technology in ENT surgery has been used in certain areas of head and neck cancer care but, in this article, we hear of an exciting development from the team at Guy’s & St Thomas’. Advances in surgical robotic technology...
The 29th of November 2024 marks the 75th anniversary of the first intraocular lens implant by our Founder, Sir Harold Ridley FRS. The United Kingdom & Ireland Society of Cataract & Refractive Surgeons (UKISCRS) is marking the event with a...
The aim is to present a case of neurofibromatosis type-1 (NF-1), also known as von Recklinghausen disease, who presented with bilateral multiple choroidal nodular nevi following chemotherapy and mastectomy for breast cancer. Neurofibromatosis type-1 presents as a wide range of...
A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.
Urgent action must be taken to improve street design and accessibility for blind and partially sighted pedestrians says the Royal National Institute of Blind People (RNIB) Scotland in their latest report, ‘Street Credibility’.